Infectious Disease

Recall announced for Zicam Extreme Congestion Relief Nasal Gel

Zicam Extreme Congestion Relief nasal gel

(Best Syndication News) - The U.S. Food and Drug Administration announced that Matrixx Initiatives is recalling one lot of Zicam Extreme Congestion Relief nasal gel. The company announced the recall after a single sample tested positive for Burkholderia cepacia during a routine check at their manufacturing location. Now other samples tested positive, however, out of extreme caution, a recall has been announced.

There is very little medical risk for Burkholderia cepacia. There is a potential to infect individuals that have a weakened immune system or a chronic lung condition. An infection of Burkholderia cepacia can be difficult to get rid of with antibiotics because it is resistant.

Fish Oil Supplements helped Heal Bedsores

(Best Syndication News) - Taking fish oil supplements may help bedsores heal in critically ill patients, according to a study from the Tel Aviv University. The researchers noticed a 20-25 percent reduction in pressure ulcers when eight grams of fish oil were taken daily for three weeks. The results were published in the British Journal of Nutrition and the American Journal of Critical Care.

Prof. Pierre Singer of the Sackler Faculty of Medicine explained that bedsores are a common problem for critically ill patients because of constant pressure on the skin and tissue. Bedsores form from a lack oxygen because the blood flow is reduced and there is skin wetness. Other studies have found fish oil supplements were helpful for lowering blood pressure and reducing inflammation of the skin and in joints.

Cherry Tomato Recall announced for possible Salmonella Contamination

Food Label - credit: FDA

(Best Syndication News) - The U.S. Food and Drug Administration (FDA) announced the voluntary recall of cherry tomatoes from Captial City Fruit, Inc that was shipped by Rio Queen Citrus Inc. The product may be contaminated with Salmonella. The cherry tomatoes were shipped on November 10 and Rio Queen Citrus Inc. received the produce on November 12. No illnesses were reported in association with this recall.

The recall involves certain lot numbers of the Capital Brand Clamshell Cherry Tomatoes, which were delivered to retail outlets between November 14th and November 18th.

Nestle announces recall of Nesquik Chocolate Powder Drink Mix

Nestlé Nesquick Chocolate Powdered Drink Mix - credit: Nestlé USA

(Best Syndication News) - Nestlé USA announced the voluntary recall of certain packages of their Nestlé Nesquick chocolate powder drink mix. Ingredients from their supplier, Omya Inc., had calcium carbonate recalled because of possible Salmonella contamination. No illnesses have been reported in association with this recall, although the Nesquick product was distributed nationwide.

Only the powdered packages that came in the 10.9, 21.8 and 40.7 ounce canister sizes and have the “BEST BEFORE Oct 2014” are involved in the recall. The product was manufactured in early October 2012. Only the products with the matching UPC code and production codes are being recalled (see list below). All other package sizes or ones outside the Best-by date are not involved in the recall. Additionally, the ready-to-drink products are not involved in the recall.

Vitamin D supplements did not ease Colds in Duration or Frequency

(Best Syndication News) - A study from New Zealand found that vitamin D3 supplements did not reduce the frequency or severity of colds. The randomized controlled trial tested monthly dosage of 100,000 IUs of vitamin D3. The results were published in the October 3, 2012 issue of JAMA.

The researchers wanted to see if supplementation would reduce the frequency and severity of respiratory tract infections. Previous studies have suggested that a vitamin D insufficiency would make a person more vulnerable for catching a cold.

David R. Murdoch, M.D., of the University of Otago, Christchurch, New Zealand, and colleagues recruited 322 healthy adults who participated in the study between February 2010 and November 2011. Half of the participants were randomly assigned to be given 200,000 IU of vitamin D3 orally at the start of the trial, then another 200,000 IU dose one month later. Then, they were given 100,000 IU dose each month for the remainder of the study. The remaining half was given a placebo pill to take on the same schedule and method. The study lasted for 18 months.

Syndicate content


Post to Facebook

Important: The material on Best Syndication is for informational purposes only and is not meant to be advice. Authors may have or will receive monetary compensation from the company's product/s mentioned. You should always seek professional advice before making any legal, financial or medical decisions and this website cannot substitute or replace any trained professional consultation.
Use of this site means that you agree to our TERMS OF SERVICE

Advertise On This Site
Copyright © 2006-2015 By Best Syndication All Rights Reserved